TREA

86290520 - CAIM

Follow

Information

  • Trademark
  • 86290520
  • Serial Number
    86290520
  • Filing Date
    May 23, 2014
    10 years ago
  • Transaction Date
    March 13, 2017
    7 years ago
  • Status Date
    March 13, 2017
    7 years ago
  • Published for Opposition Date
    June 09, 2015
    9 years ago
  • Location Date
    August 27, 2016
    7 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    LOVELACE, JAMES B
  • Attorney Docket Number
    1338.11.CAIM
    Attorney Name
    Bradley P. Hartman
    Law Office Assigned Location Code
    N10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CAIM
Case File Statements
  • GS0011: Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Genetic identity tests comprised of reagents; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties for scientific and research use
  • GS0051: Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting mutation in prion genes for medical purposes; Clinical diagnostic preparations for medical use; Chemical reagents for medical analysis; Chemical diagnostic preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of immunotherapy, and for identifying and characterizing immune dysfunction
  • GS0411: Consulting services in the field of medical education, namely, providing education and training information relating to the identification, diagnosis and treatment of medical and genetic conditions; Education services, namely, providing live and on-line continuing professional education seminars in the medical, scientific and genetics field; Education services, namely, providing training programs in the field of genetics; Conducting workshops and seminars in genetic testing and disease identification and treatment; Educational services, namely, organization of seminars educational conference attendee working groups and research groups and conventions in the fields of medicine, genetics and scientific research; On-line journals, namely, blogs featuring commentary and information in the fields of DNA identification techniques, practices, and tools; Organization of educational conferences and symposia for the discussion, dissemination and exchange of scientific data and ideas on topics of interest to the scientific community; Providing educational demonstrations regarding biology, molecular biology, genetics, DNA sequencing and bioinformatics; Conducting classes, seminars and workshops in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study and distributing course materials in connection therewith; Educational services, namely, conducting educational programs in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Educational services, namely, conducting on-line exhibitions and displays and interactive exhibits in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Organizing exhibitions for education in biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Providing courses of instruction in the fields of biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study and distributing course material in connection therewith; Teaching in the fields of biology, molecular biology, genetics, genomics, DNA sequencing and bioinformatics and nature study
  • GS0421: Conducting medical and scientific educational research for others on the subjects of biology, molecular biology, genetics, genomics, DNA sequencing, and bioinformatics; Medical and scientific research in the field of genetic testing; Development and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, DNA sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; DNA collection, testing and analysis services for scientific research purposes; Medical and scientific research, development and scientific consulting in the field of oncology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for medical and scientific research purposes; Medical and scientific research relating to the design and development of cancer treatment therapies; Conducting clinical and pre-clinical trials for others; Diagnostic services for equipment in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids; Research and development of identification and treatment methods for hereditary factors leading to disease; Testing and evaluation for scientific purposes, namely, identification of target molecules for cancer treatment; Testing and evaluation for scientific purposes, namely, proteogenomic profiling; DNA-sequencing for scientific research purposes; Targeted pharmaceutical drug development services; Testing and evaluation for scientific purposes, namely, genotyping; Testing and evaluation for scientific purposes, namely, gene screening; Gene isolation and gene expression analysis for scientific research purposes; Testing and evaluation for scientific purposes, namely, gene mapping; Gene analysis and biomarker discovery for scientific research purposes; Collection and preservation of DNA for research purposes
  • GS0441: Diagnosis and treatment of medical conditions; Genetic testing for diagnostic purposes; Genomic testing for diagnostic purposes; Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic testing, monitoring and reporting services; Medical evaluation services; Medical monitoring services; Medical diagnostic, prognostic and theranostic screening and testing; Collection and preservation of DNA for medical purposes; Consulting services in the field of healthcare and cancer diagnoses; Providing a website featuring health and healthcare information related to cancer research, testing and screening; Genetic testing for medical purposes; Providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; Providing genetics assessments in the nature of genetic counseling; Molecular profiling services of patients for use in providing medical and related health care services to patients
Case File Event Statements
  • 3/13/2017 - 7 years ago
    37 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6
  • 3/13/2017 - 7 years ago
    36 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 9/7/2016 - 7 years ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 9/6/2016 - 7 years ago
    34 - EXTENSION 2 GRANTED Type: EX2G
  • 8/4/2016 - 7 years ago
    33 - EXTENSION 2 FILED Type: EXT2
  • 8/27/2016 - 7 years ago
    32 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 8/4/2016 - 7 years ago
    31 - TEAS EXTENSION RECEIVED Type: EEXT
  • 1/30/2016 - 8 years ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/28/2016 - 8 years ago
    29 - EXTENSION 1 GRANTED Type: EX1G
  • 1/28/2016 - 8 years ago
    28 - EXTENSION 1 FILED Type: EXT1
  • 1/28/2016 - 8 years ago
    27 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/4/2015 - 8 years ago
    26 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/9/2015 - 9 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/9/2015 - 9 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/20/2015 - 9 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/1/2015 - 9 years ago
    22 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 5/1/2015 - 9 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/1/2015 - 9 years ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/1/2015 - 9 years ago
    19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/1/2015 - 9 years ago
    18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/1/2015 - 9 years ago
    17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/30/2015 - 9 years ago
    16 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 4/14/2015 - 9 years ago
    15 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 3/28/2015 - 9 years ago
    14 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 3/28/2015 - 9 years ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 3/10/2015 - 9 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/6/2015 - 9 years ago
    11 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/26/2015 - 9 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/25/2015 - 9 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/25/2015 - 9 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/24/2015 - 9 years ago
    7 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA
  • 2/24/2015 - 9 years ago
    6 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP
  • 9/15/2014 - 9 years ago
    5 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/15/2014 - 9 years ago
    4 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/15/2014 - 9 years ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/8/2014 - 9 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/6/2014 - 10 years ago
    1 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS